BRIEF published on 04/16/2025 at 08:05, 1 year 4 months ago Néovacs s'exprime sur les rumeurs concernant le PXT3003 Biopharmaceutique PXT3003 Tasly Charcot-Marie-Tooth Autorisation Marché
BRIEF published on 04/16/2025 at 08:05, 1 year 4 months ago Neovacs Addresses Rumors About PXT3003 Biopharmaceuticals Market Authorization PXT3003 Tasly Charcot-Marie-Tooth
BRIEF published on 04/16/2025 at 08:05, 1 year 4 months ago ADLPartner : Publication du rapport financier annuel 2024 Communication Rapport Financier 2024 ADLPartner DÉKUPLE
BRIEF published on 04/16/2025 at 08:05, 1 year 4 months ago ADLPartner: Publication of the 2024 annual financial report Financial Report Communication 2024 ADLPartner DÉKUPLE
BRIEF published on 04/16/2025 at 07:35, 1 year 4 months ago Vallourec obtient la note "Investment Grade" des agences de notation Investment Grade Fitch Ratings Vallourec Plan New Vallourec Structure De Coûts
BRIEF published on 04/16/2025 at 07:35, 1 year 4 months ago Vallourec obtains "Investment Grade" rating from rating agencies Investment Grade Fitch Ratings Vallourec New Vallourec Plan Cost Structure
BRIEF published on 04/16/2025 at 07:35, 1 year 4 months ago Sensorion organise un symposium à la conférence ISIET 2025 Thérapie Génique Perte Auditive SENS-401 Innovations Médicales Symposium Sensorion
BRIEF published on 04/16/2025 at 07:35, 1 year 4 months ago Sensorion is organizing a symposium at the ISIET 2025 conference Gene Therapy Hearing Loss SENS-401 Medical Innovations Sensorion Symposium
BRIEF published on 04/16/2025 at 07:35, 1 year 4 months ago Bourse Direct : Activité en hausse malgré une baisse du chiffre d'affaires Chiffre D'affaires Clients EXOE Volume D'ordres Revenus Courtage
BRIEF published on 04/16/2025 at 07:35, 1 year 4 months ago Bourse Direct: Activity up despite a drop in turnover Order Volume Turnover Customers EXOE Brokerage Income
Published on 09/11/2026 at 17:00, 3 hours 16 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/11/2026 at 17:00, 3 hours 16 minutes ago Critical Elements sélectionné pour inclusion dans le prospectus du sommet Canadien de l'investissement, mettant le projet en valeur auprès d'investisseurs mondiaux de premier plan
Published on 09/11/2026 at 15:25, 4 hours 51 minutes ago Revolve Signs Agreement to Acquire 9.6 MW Operating Wind Project in the US and Secures Project-Level Debt Financing with EDC and Vancity
Published on 09/11/2026 at 15:00, 5 hours 16 minutes ago Regentis Biomaterials Reports First Half 2026 Financial Results and Provides Corporate Update
Published on 09/11/2026 at 14:30, 5 hours 46 minutes ago AIAI Holdings Enters into Extended Lock-up Agreements to Protect Long-Term Stockholder Value
Published on 09/11/2026 at 19:44, 31 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 2 hours 1 minute ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 18:00, 2 hours 16 minutes ago ROCTOOL: INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 09/11/2026 at 07:00, 13 hours 16 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 13 hours 16 minutes ago Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 13 hours 16 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 13 hours 16 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
